Obesity drug market to gain as Indians pop the pill and Chinese bring more
Mumbai: A flood of oral GLP1 weight-loss pills, including from China, may redraw India’s obesity treatment market by this year-end, said industry executives and top endocrinologists. Nearly a dozen oral…
Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23
New Delhi: Aurobindo Pharma Ltd on Tuesday said it has set April 23 as the opening date for its Rs 800 crore buyback offer. The closing date for the buyback…
Boehringer Ingelheim launches AI centre for pharma research in London
Bengaluru: German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning in London, it said on Monday, as it seeks to expand its AI capabilities in…
Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March
India’s pharmaceutical exports rose more than 2% year on year to $31.11 billion in FY26 despite a 23% decline in March amid the fallout of the West Asia war. A…
Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates
New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…
Piramal, Ajinomoto team on ADC development and manufacturing
Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…
Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid
New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…
Cancer cure must not be hostage to Big Pharma
In recent years, immunotherapy has expanded the limits of cancer treatment. Therapies that harness the body’s immune system to fight malignant cells have improved survival rates in cancers once considered…
GLP-1 drugs emerge as a new option for Indian women battling PCOS
Pune:- A woman, 34, diagnosed with polycystic ovary syndrome, or PCOS, as a teenager, saw her first natural menstrual cycle in February—six months after starting Mounjaro for weight management. This…
Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid
Aurobindo Pharma announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per ml. The…
